Limitations, agreements, and source contact

Dose Escalation Trial of Denileukin Diftitox (Ontak) Post Autologous Transplantation · Source last updated 2017-06-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

limitations And Caveats

description

Analysis was not completed due to the small number of patients accrued and drugs were unavailable.

point Of Contact

email

alkadhiz@karmanos.org

organization

Barbara Ann Karmanos Cancer Institute

phone

(313) 576-8022

title

Zaid Al-Kadhimi, M.D.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice